STAB — Statera Biopharma Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $5.97m
- $1.49m
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc
Brief: Nasdaq Resumes Trading In Statera Biopharma Inc
Brief: Statera Biopharma Receives Notification Letter From Nasdaq Regarding Form 10-Q Filing
Brief: Statera Biopharma And Lay Sciences Inc Announce Intent To Enter Strategic Partnership To License The Manufacturing Rights To Certain Lay Sciences IgY Products
Brief: Statera Biopharma And Immune Therapeutics Inc. Announce Strategic Agreement For Rights To Low Dose Naltrexone
Brief: Statera Biopharma Receives Notification Letter From Nasdaq Regarding Form 10-K Filing
Brief: Statera Biopharma And Coeptis Therapeutics Announce Strategic Agreement For Rights To Entolimod
Statera rises on potential drug platform acquisition deal with Coeptis
Brief: Coeptis Therapeutics Announces Intent To Acquire Tlr5 Agonist Platform
Brief: Statera Biopharma - Received Letter From Avenue Regarding Default With Respect To Loan, Security Agreement
Brief: Statera Biopharma Receives Notice From Nasdaq That Co No Longer Meets Minimum Bid Price Requirements
U.S. STOCKS ON THE MOVE-JX Luxventure, Statera Biopharma, Pfizer
U.S. STOCKS ON THE MOVE-Tesla, Nike, JX Luxventure
Brief: Statera Biopharma Announces Pricing Of $5.7 Mln Underwritten Public Offering
U.S. STOCKS ON THE MOVE-Tesla, Okta, Riot Blockchain
U.S. STOCKS ON THE MOVE-Tesla Inc, Apple Inc, Huya Inc